News
Anax Metals (ASX: ANX) has received a $103 million strategic investment and funding package from Mineral Development Partners ...
Immutep (ASX: IMM) has announced a solid median overall survival (OS) rate in Cohort B of its TACTI-003 (Keynote-C34) Phase ...
Evergreen Lithium (ASX: EG1) is making what it describes as a “transformational” move with its acquisition of the Leonora ...
An optimised scoping study for Barton Gold’s (ASX: BGD) (OTCQB: BGDFF) large-scale Tunkillia project in South Australia has ...
Distributed ledger technology specialist NoviqTech (ASX: NVQ) will participate in the China International Fair for Trade in Services (CIFTIS) 2025 in Beijing this September, where Australia will be ...
Results from Blackstone Minerals’ (ASX: BSX) initial drilling program at the Mankayan copper-gold porphyry project seem to vindicate the company’s recent move into the Philippines. Best known for its ...
One of the toughest choices many investors face is between investing for capital growth or for dividends. Go for growth alone and you may face greater volatility and a lack of income while investing ...
Geopolitical events during the March quarter have strengthened International Graphite’s (ASX: IG6) belief that its Springdale project in Western Australia has the potential to become a significant ...
Platinum Asset Management (ASX: PTM) has confirmed it is in early discussions with Melbourne-based hedge fund L1 Capital regarding a potential merger of the two companies. The deal would combine the ...
EVE Health (ASX: EVE) will execute a change in direction from functional foods to regulated health markets with a $3 million acquisition of biotech company Nextract and its oral delivery technologies.
Drug developer Dimerix (ASX: DXB) and US biopharmaceuticals company Amicus Therapeutics have entered into an exclusive US licence agreement for the commercialisation of Dimerix’s lead candidate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback